Intravenous Vitamin C

Dr. Kipfer uses Intravenous Vitamin C quite frequently in the treatment of cancer. He has found that his patients experience fewer side effects from chemotherapy and radiation as well as reduced pain associated with cancer. He also has a number of patients where their tumour markers have reduced steadily while on the treatment. Intravenous Vitamin C is typically used with patient while on chemotherapy and radiation. A typical cancer patient will receive 50-75 grams of intravenous vitamin C 2-3 times a week.

Benefit summary:

  • IV route is the only route to acquire therapeutic concentration.
  • IV Vitamin C stops the proliferation of cancer cells by inhibiting the enzyme hyaluronidase which cancer cells emit to break down and invade healthy tissue.
  • IV Vitamin C supports the Immune system, assists in the healing of wounds and protects against infection.
  • IV Vitamin C is preferentially toxic to cancer cells by increasing intracellular hydrogen peroxide. Cancer cells can’t process the hydrogen peroxide due to a lack of the enzyme catalase, which normal cells have in abundance.
  • IV Vitamin C corrects an ascorbate deficiency, often seen in cancer patients.
  • IV Vitamin C helps prevent cellular free radical damage.
  • IV Vitamin C increases the quality of life.
  • IV Vitamin C extends life.
  • IV Vitamin C works along with chemotherapy.

Research studies:

Intravenously administered vitamin C as cancer therapy: three cases

High Doses of Multiple Antioxidant Vitamins: Essential Ingredients in Improving the Efficacy of Standard Cancer Therapy

Changes of Terminal Cancer Patients' Health-related Quality of Life after High Dose Vitamin C Administration